Beranda Eli Lilly shares phase 3 data on triple agonist weight loss drug retatrutide Eli Lilly shares phase 3 data on triple agonist weight loss drug retatrutide personAchmad Shoffan 02.39 0 share source https://www.investing.com/news/stock-market-news/eli-lilly-shares-phase-3-data-on-triple-agonist-weight-loss-drug-retatrutide-4729608 Facebook Twitter Whatsapp Lebih baru Lebih lama
